{
  "figure_1": "Study flow diagram.",
  "figure_2": "Risk of bias summary: review authors' judgements about each risk of bias item for each included study.",
  "figure_3": "Forest plot of comparison: 1 Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) versus placebo, outcome: 1.1 Dry eye symptoms, measured using the OSDI score [OSDI] units.",
  "figure_4": "Forest plot of comparison: 1 Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) versus placebo, outcome: 1.3 Schirmer test (tear production) (mm/5 min).",
  "figure_5": "Forest plot of comparison: 1 Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) versus placebo, outcome: 1.4 Tear break‐up time (TBUT) measured using fluorescein (seconds).",
  "figure_6": "Forest plot of comparison: 1 Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) versus placebo, outcome: 1.6 Adverse event: gastrointestinal disorders.",
  "figure_7": "Forest plot of comparison: 2 Combined omega‐3 and omega‐6 PUFAs versus placebo, outcome: 2.1 Schirmer test (tear production) (mm/5 min).",
  "figure_8": "Forest plot of comparison: 2 Combined omega‐3 and omega‐6 PUFAs versus placebo, outcome: 2.2 TBUT: Mean change from baseline (seconds).",
  "figure_9": "Forest plot of comparison: 3 Oral omega‐3 PUFAs plus conventional therapy versus conventional therapy alone (two RCTs), outcome: 3.1 OSDI score: mean score at study endpoint [OSDI units].",
  "figure_10": "Forest plot of comparison: 4 Oral long‐chain omega‐3 PUFAs versus oral omega‐6 PUFAs, outcome: 4.1 Dry eye symptoms, measured using the OSDI score [OSDI] units.",
  "figure_11": "Forest plot of comparison: 4 Oral long‐chain omega‐3 PUFAs versus oral omega‐6 PUFAs, outcome: 4.5 Adverse event: gastrointestinal disorders."
}